Injective, a high-frequency protocol for decentralized derivative trading, has seen a surge in popularity and price, raising questions about its sustainability. The adoption by
Canary Capital for an ETF trust and growing interest in
INJ price resurgence are promising factors. INJ's bold move to adopt
AI to push dApp development further solidifies its innovative stance.
Deutsche Telekom's backing and its subsidiary becoming a validator for Injective's blockchain increases INJ's legitimacy. Its recent 3.0 upgrade sparked a rally thanks to its deflationary promise. A surge in
dApp development, cross-chain AI agent hub launch, on-chain AI agents, and native EVM support further underscore the potential of INJ. Despite the fluctuations, expert predictions remain positive and suggest profitability. INJ's interoperable ecosystem makes it an attractive investment opportunity, especially for DeFi and DEXs. The launch of Agora's AUSD as its first native stablecoin and the sensational presale of BlockDAG vs. Stack(STX) & Injective (INJ) testify to this growing clout.
Injective Coin News Analytics from Sun, 13 Feb 2022 08:00:00 GMT to Wed, 02 Jul 2025 12:30:15 GMT -
Rating 6
- Innovation 9
- Information 7
- Rumor 3
